Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MEDI-TECH ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.8% 0.8%   Bankruptcy risk   0.9% 0.0% 1.9% 2.9% 5.3% 1.5% 6.7% 6.7%   Credit score (0-100)   89 0 70 56 42 74 36 36   Credit rating   A N/A A BBB BBB A BBB BBB   Credit limit (kDKK)   492.9 0.0 1.1 0.0 0.0 4.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,158 0.0 1,901 1,265 499 1,116 0.0 0.0   EBITDA   1,848 0.0 377 -322 -1,165 677 0.0 0.0   EBIT   1,819 0.0 349 -342 -1,182 569 0.0 0.0   Pre-tax profit (PTP)   1,822.8 0.0 342.1 -225.1 -1,144.9 568.7 0.0 0.0   Net earnings   1,406.5 0.0 249.0 -181.4 -895.7 453.4 0.0 0.0   Pre-tax profit without non-rec. items   1,823 0.0 342 -225 -1,145 569 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   243 0.0 54.2 734 718 610 0.0 0.0   Shareholders equity total   4,321 0.0 2,770 2,259 1,363 972 892 892   Interest-bearing liabilities   639 0.0 19.8 21.1 19.8 122 0.0 0.0   Balance sheet total (assets)   6,100 0.0 3,293 2,731 1,679 1,517 892 892   Net Debt   -3,492 0.0 -1,535 -414 -142 -234 -292 -292     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,158 0.0 1,901 1,265 499 1,116 0.0 0.0   Gross profit growth   9.2% -100.0% 0.0% -33.5% -60.5% 123.5% -100.0% 0.0%   Employees   2 0 2 2 2 2 0 0   Employee growth %   0.0% -100.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,100 0 3,293 2,731 1,679 1,517 892 892   Balance sheet change%   47.5% -100.0% 0.0% -17.1% -38.5% -9.7% -41.2% 0.0%   Added value   1,848.0 0.0 377.2 -322.2 -1,161.6 676.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -81 -243 26 660 667 -315 -610 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 0.0 1.0 -1.0 -2.0 1.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   57.6% 0.0% 18.4% -27.1% -236.6% 51.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   35.9% 0.0% 11.5% -7.2% -51.8% 35.6% 0.0% 0.0%   ROI %   39.8% 0.0% 13.1% -8.4% -62.3% 46.0% 0.0% 0.0%   ROE %   38.9% 0.0% 9.0% -7.2% -49.5% 38.8% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   70.8% 0.0% 84.1% 82.7% 81.2% 64.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -189.0% 0.0% -407.1% 128.5% 12.2% -34.6% 0.0% 0.0%   Gearing %   14.8% 0.0% 0.7% 0.9% 1.4% 12.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.8% 0.0% 375.2% 33.5% 15.6% 0.7% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   4.3 0.0 7.7 4.2 3.0 1.7 0.0 0.0   Current Ratio   4.3 0.0 7.7 4.2 3.0 1.7 0.0 0.0   Cash and cash equivalent   4,131.0 0.0 1,555.2 435.3 161.5 355.9 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   4,194.1 0.0 2,818.0 1,524.7 645.7 361.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   924 0 189 -161 -581 338 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   924 0 189 -161 -582 338 0 0   EBIT / employee   910 0 175 -171 -591 285 0 0   Net earnings / employee   703 0 125 -91 -448 227 0 0